Buy GLP-3R 20mg

259.99

Buy GLP-3R 20mg

Research Benefits:

  • Multi‑agonist (GLP‑1R/GIPR/GCGR) for receptor signaling assays
  • Supports in vitro study of glucose regulation and insulin pathways
  • Useful for probing energy balance mechanisms across incretin/glucagon signaling
  • Enables assessment of metabolic/cardiometabolic biomarkers in cell models

Description

Buy GLP-3R 20mg

GLP-3R 20mg is an innovative research peptide that functions as a triple agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multifaceted approach positions GLP-3R at the forefront of metabolic research, particularly in studies related to obesity, type 2 diabetes, and associated metabolic disorders.

Key Features:

  • Synthesized to the highest purity standards, ensuring consistent and reliable research outcomes.
  • Each batch undergoes rigorous quality control measures to maintain exceptional purity and efficacy.
  • Provided in a lyophilized powder form to preserve stability and bioactivity under recommended storage conditions.

Applications:

  • Investigating the peptide’s role in promoting significant weight loss and its underlying mechanisms.
  • Exploring its effects on insulin sensitivity, glucose metabolism, and potential applications in type 2 diabetes management.
  • Assessing its impact on cardiovascular health markers and liver fat reduction.
  • Studying its influence on energy expenditure and fat oxidation processes.

Specifications and Documentation

  • Material Safety Data Sheet (MSDS): Coming Soon.
  • Handling and Storage Instructions: Coming Soon.

GLP-3R 20mg offers researchers a cutting-edge tool to delve into the complexities of metabolic regulation, providing insights that could pave the way for novel therapeutic strategies in combating obesity and metabolic diseases.

Buy GLP-3R 20mg

Reviews

There are no reviews yet.

Be the first to review “Buy GLP-3R 20mg”

Your email address will not be published. Required fields are marked *